# Advisor Review - GPT-5.4 (R1)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-09T10:54:13.062572
**Route:** OpenRouter + LaTeX
**Paper Hash:** cf7b8bfa55e04914
**Tokens:** 24418 in / 1586 out
**Response SHA256:** 3e86b107a36e051d

---

I checked the paper for fatal errors only, focusing on data-design alignment, regression sanity, completeness, and internal consistency across the reported tables and claims.

Findings:

- **Data-design alignment:** No fatal mismatch found. Treatment begins in **December 2022**, and the data run through **December 2025**, so post-treatment data exist. The panel counts are internally consistent:
  - 96 months total = 59 pre + 37 post
  - 22 Welsh LAs × 59 = **1,298** pre observations
  - 22 Welsh LAs × 37 = **814** post observations
  - Table 1/sample counts and text line up with the stated design.

- **Regression sanity:** I scanned the reported regression tables:
  - **Table `tab:main_did`**
  - **Table `tab:composition`**
  - **Table `tab:ddd`**
  - **Table `tab:robustness`**
  - **Table `tab:robustness_full`**
  - **Table `tab:by_type`**
  - **Table `tab:prs_terciles`**
  - **Table `tab:sde`**
  
  No fatal numerical pathologies found:
  - No impossible \(R^2\) values
  - No negative SEs
  - No NA/NaN/Inf in regression outputs
  - No coefficients or SEs that are obviously broken by the thresholds you specified

- **Completeness:** No fatal incompleteness found in the results presentation.
  - Regression tables report **standard errors**
  - Regression tables report **sample sizes / number of observations**
  - Referenced tables and figures in the manuscript appear to exist in the LaTeX source
  - Analyses described in the methods are reported somewhere in the paper or appendix

- **Internal consistency:** No fatal contradiction found between text and tables.
  - Main estimates cited in the abstract/introduction match the corresponding tables
  - Treatment timing is consistently December 2022
  - Sample period is consistently 2018–2025
  - Placebo/property-type/DDD claims match the reported coefficients

I do not see a fatal error that would make journal submission embarrassing on mechanical or design-consistency grounds.

ADVISOR VERDICT: PASS